Syros Pharmaceuticals Inc. diskutieren
Syros Pharmaceuticals Inc.
WKN: A3DT8V / Symbol: SYRS / Name: Syros Pharmaceuticals / Aktie / Pharmazeutika / Small Cap /
4,70 €
-1,26 %
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $13.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for SYRS provided by MarketBeat
Neueste Beiträge
DA_Davidson in Douglas Dynamics Inc. diskutieren